stella
beta
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment — Stella
Recruiting
Back to Intracranial Meningioma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(10 sites)
United States
Yale University, New Haven, Connecticut
Baptist MD Anderson Cancer Center, Jacksonville, Florida
University of Miami, Miami, Florida
Baptist Health Medical Group Oncology, Miami, Florida
Piedmont Healthcare, Atlanta, Georgia
Show all 10 locations
View full record on ClinicalTrials.gov